Inger Højris

2.0k total citations
20 papers, 1.4k citations indexed

About

Inger Højris is a scholar working on Oncology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Inger Højris has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Inger Højris's work include Breast Cancer Treatment Studies (11 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Cancer Treatment and Pharmacology (5 papers). Inger Højris is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Cancer Treatment and Pharmacology (5 papers). Inger Højris collaborates with scholars based in Denmark and Sweden. Inger Højris's co-authors include Marie Overgaard, Jens Overgaard, Jörn Andersen, Jens Christensen, Marianne Ewertz, Maj‐Britt Jensen, Dorte Nielsen, Erik Jakobsen, Søren Cold and K. Gunnarsdóttir and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Inger Højris

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inger Højris Denmark	13	888	512	268	254	228	20	1.4k
Gideon Zamba United States	19	454 0.5×	170 0.3×	159 0.6×	250 1.0×	249 1.1×	47	1.3k
Jorge García Spain	23	473 0.5×	317 0.6×	801 3.0×	400 1.6×	239 1.0×	87	1.5k
Mohamedtaki Abdulaziz Tejani United States	22	1.0k 1.2×	158 0.3×	454 1.7×	171 0.7×	635 2.8×	80	1.7k
Julie Lemieux Canada	20	852 1.0×	265 0.5×	241 0.9×	343 1.4×	153 0.7×	83	1.6k
Marco Venturini Italy	19	1.0k 1.1×	401 0.8×	236 0.9×	213 0.8×	90 0.4×	43	1.9k
Rolland J. Barrett United States	22	803 0.9×	175 0.3×	311 1.2×	238 0.9×	1.0k 4.5×	33	3.5k
Michelle Shayne United States	19	774 0.9×	283 0.6×	293 1.1×	268 1.1×	84 0.4×	44	1.4k
May Lin Tao United States	16	386 0.4×	80 0.2×	280 1.0×	195 0.8×	193 0.8×	28	1.4k
E. Verger Spain	20	629 0.7×	125 0.2×	648 2.4×	206 0.8×	276 1.2×	48	1.9k
Teresa D'Angelo United States	15	943 1.1×	1.2k 2.3×	188 0.7×	157 0.6×	595 2.6×	19	2.1k

Countries citing papers authored by Inger Højris

Since Specialization

Citations

This map shows the geographic impact of Inger Højris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Højris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Højris more than expected).

Fields of papers citing papers by Inger Højris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Højris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Højris. The network helps show where Inger Højris may publish in the future.

Co-authorship network of co-authors of Inger Højris

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Højris. A scholar is included among the top collaborators of Inger Højris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Højris. Inger Højris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Maj‐Britt, Eva Balslev, Ann Knoop, et al.. (2024). Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial. Journal of Clinical Oncology. 43(4). 373–380. 3 indexed citations

Overgaard, Marie, Hanne Melgaard Nielsen, Trine Tramm, et al.. (2022). Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiotherapy and Oncology. 170. 4–13. 31 indexed citations

Nissen, Eva Rames, Robert Zachariae, Maja O’Connor, et al.. (2021). Internet-delivered Mindfulness-Based Cognitive Therapy for anxiety and depression in cancer survivors: Predictors of treatment response. Internet Interventions. 23. 100365–100365. 20 indexed citations

Overgaard, Marie, Trine Tramm, Inger Højris, et al.. (2020). OC-0325: Postmastectomy RT in high-risk breast cancer. A 30-year update of the DBCG 82bc randomized trial.. Radiotherapy and Oncology. 152. S171–S171. 1 indexed citations

Nissen, Eva Rames, Maja O’Connor, Viktor Kaldo, et al.. (2019). Internet‐delivered mindfulness‐based cognitive therapy for anxiety and depression in cancer survivors: A randomized controlled trial. Psycho-Oncology. 29(1). 68–75. 85 indexed citations

Møller, Andreas Buch, Simon Lønbro, Jean Farup, et al.. (2019). Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy. Journal of Cancer Research and Clinical Oncology. 145(6). 1449–1460. 30 indexed citations

Cour, Karen la, et al.. (2018). The ‘Cancer Home-Life Intervention’: A randomised controlled trial evaluating the efficacy of an occupational therapy–based intervention in people with advanced cancer. Palliative Medicine. 32(4). 744–756. 27 indexed citations

Ejlertsen, Bent, Malgorzata Tuxen, Erik Jakobsen, et al.. (2017). Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for EarlyTOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial. Journal of Clinical Oncology. 35(23). 2639–2646. 47 indexed citations

Lønbro, Simon, Jean Farup, Thomas Schmidt Voss, et al.. (2017). Lean body mass, muscle fibre size and muscle function in cancer patients during chemotherapy and 10 weeks exercise. SHILAP Revista de lepidopterología. 2(1). 1–15. 12 indexed citations

10.

Nissen, Eva Rames, Maja O’Connor, Viktor Kaldo, et al.. (2016). Therapist-assisted internet-delivered Mindfulness-Based Cognitive Therapy for symptoms of depression, anxiety and stress among breast- and prostate cancer survivors – A feasibility study. 1 indexed citations

11.

Johannsen, Maja, Maja O’Connor, Mia Skytte O’Toole, et al.. (2016). Efficacy of Mindfulness-Based Cognitive Therapy on Late Post-Treatment Pain in Women Treated for Primary Breast Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology. 34(28). 3390–3399. 102 indexed citations

12.

Ewertz, Marianne, Maj‐Britt Jensen, K. Gunnarsdóttir, et al.. (2010). Effect of Obesity on Prognosis After Early-Stage Breast Cancer. Journal of Clinical Oncology. 29(1). 25–31. 445 indexed citations

13.

Ejlertsen, Bent, Inger Højris, Steinbjørn Hansen, et al.. (2003). Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group. The Breast. 12(1). 42–50. 6 indexed citations

14.

Højris, Inger, Jörn Andersen, Marie Overgaard, & Jens Overgaard. (2000). Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone. Acta Oncologica. 39(3). 355–372. 102 indexed citations

15.

Højris, Inger, Niels Peter Rønnow Sand, Jørn Andersen, Michael Rehling, & Marie Overgaard. (2000). Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiotherapy and Oncology. 55(2). 163–172. 27 indexed citations

16.

Højris, Inger, et al.. (2000). Treatment of Breast-Cancer-related Lymphedema With or Without Manual Lymphatic Drainage: A Randomized Study. Acta Oncologica. 39(3). 399–405. 192 indexed citations

17.

Højris, Inger, Marie Overgaard, Jens Christensen, & Jens Overgaard. (1999). Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. The Lancet. 354(9188). 1425–1430. 254 indexed citations

18.

Højris, Inger, J. Andersen, Marie Overgaard, & Jens Overgaard. (1999). Late treatment related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. European Journal of Cancer. 35. S206–S206. 7 indexed citations

19.

Andersen, Lars L., Inger Højris, & J. Andersen. (1999). Treatment of breast cancer related lymphedema with or without manual lymphatic drainage: a randomized study. European Journal of Cancer. 35. S30–S31. 8 indexed citations

20.

Højris, Inger, et al.. (1997). Adjuvant radiotherapy in breast cancer and risk of ischaemic heart disease. European Journal of Cancer. 33. S80–S80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact